Sridhar Kosaraju
Direktor/Vorstandsmitglied bei 10X GENOMICS, INC.
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von Sridhar Kosaraju
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
10X GENOMICS, INC. | Direktor/Vorstandsmitglied | 01.03.2019 | - |
Independent Dir/Board Member | 01.03.2019 | - | |
NEVRO CORP. | Direktor/Vorstandsmitglied | 31.08.2021 | - |
Independent Dir/Board Member | 31.08.2021 | - | |
Inscripta, Inc.
Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Direktor/Vorstandsmitglied | 27.10.2020 | - |
Vorstandsvorsitzender | 27.10.2020 | - | |
Präsident | 27.10.2020 | - | |
Testing For America | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Sridhar Kosaraju
Ehemalige bekannte Positionen von Sridhar Kosaraju
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PENUMBRA, INC. | Finanzdirektor/CFO | 01.05.2015 | 01.11.2019 |
Präsident | 29.08.2019 | 12.05.2020 | |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 01.01.1999 | 01.05.2015 |
Ausbildung von Sridhar Kosaraju
Massachusetts Institute of Technology | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Director/Board Member | 4 |
President | 2 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 4 |
Finance | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
PENUMBRA, INC. | Health Technology |
10X GENOMICS, INC. | Health Technology |
NEVRO CORP. | Health Technology |
Private Unternehmen | 3 |
---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Inscripta, Inc.
Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Commercial Services |
Testing For America |
- Börse
- Insiders
- Sridhar Kosaraju
- Erfahrung